Last reviewed · How we verify
NCT06031116
Efficacy of Ceramic Soft Tissue Trimming Bur Versus Conventional Scalpel Technique in Ginigival Depigmentation Procedure
NA trial testing depigmentation in Hyperpigmentation in 8 participants. Completed in 10 May 2023.
10 April 2023
Quick facts
| Lead sponsor | Ain Shams University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 8 |
| Start date | 10 October 2022 |
| Primary completion | 10 April 2023 |
| Estimated completion | 10 May 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- depigmentation
Conditions studied
- Hyperpigmentation — all drugs for Hyperpigmentation →
Sponsor
Ain Shams University
Who can join
20 and older, any sex, with Hyperpigmentation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
the investigator compares the clinical outcomes and pain levels after gingival depigmentation by ceramic soft tissue bur vs scalpel surgery
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Ceramic soft tissue trimming bur gingival depigmentation: clinical performance and patient experience. A split mouth randomized controlled trial.
Nassar SK, Abuel-Ela HA, Fouad YA. · · 2024 · PMID 38783312 · DOI 10.1186/s12903-024-04345-z -
Ceramic Soft Tissue Trimming Bur Gingival Depigmentation: Clinical Performance and Patient Experience. “A Split Mouth Randomized Controlled Trial”
Nassar SK, El-Ela HAA, Fouad YA. · · 2024 · DOI 10.21203/rs.3.rs-3943266/v1
Verify or expand the search:
- PubMed search for NCT06031116
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperpigmentation
Currently open trials in the same condition.
- NCT07162623 — Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Oziva Bioactive Gluta Fizzy Effervescent Tablets on · NA · active not recruiting
- NCT07067879 — The Effectiveness of a Novel Lip Product Containing Caulerpa Lentillifera Extract for Reducing Lip Hyperpigmentation · NA · recruiting
- NCT06349447 — Pilot Study of LED for PIE and PIH · NA · recruiting
- NCT07067515 — Effectiveness of Omega-3 Poly Unsaturated Fatty Acids on The Treatment of Gingival Hyperpigmentation · Phase 1, PHASE2 · active not recruiting
Other Ain Shams University trials
Trials by the same sponsor.
- NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
- NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
- NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
- NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
- NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06031116 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
- Last refreshed: 11 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06031116.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing